Physician profile
Natalia Hernandez Bustos
NPI 1730542432
$11,167.98
in general payments reported to CMS, 2019-2025
15 companies · $4,422 in 2025
The $4,422 reported for 2025 was more than what 83% of Urogynecology and Reconstructive Pelvic Surgery (Urology) providers received nationally (typical 2025 total: $782).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,503 · 2023: $3,922 · 2024: $1,321 · 2025: $4,422.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,534 · Travel and Lodging: $2,976 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Education: $1,154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,534.36 |
| Travel and Lodging | $2,976.39 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Education | $1,154.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avyxa Pharma, LLC | $3,668.64 | 2025 | |
| Medtronic, INC. | $3,051.29 | 2022-2025 | Interstim |
| Boston Scientific Corporation | $1,522.14 | 2023-2025 | Axonics, Solyx Sis System, Lithovue |
| Intuitive Surgical, INC. | $1,028.98 | 2023 | Davinci Xi, Da Vinci Surgical System |
| Coloplast Corp | $718.56 | 2023-2025 | Altis, Restorelle, Titan |
| Abbott Laboratories | $357.26 | 2023 | Ensite |
| Sumitomo Pharma America, INC. | $185.94 | 2023-2024 | Gemtesa, Orgovyx |
| Baxter Healthcare | $154.22 | 2023 | Tisseel, Preveleak, Floseal |
| Procept Biorobotics Corporation | $126.97 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
| Urogen Pharma, INC. | $119.82 | 2025 | |
| Abbvie INC. | $110.27 | 2024-2025 | |
| Bluewind Medical | $79.07 | 2024 | Revi |
| Endo USA, INC. | $16.03 | 2025 | Xiaflex |
| Axonics, INC. | $15.92 | 2023 | Axonics |
| Tolmar, INC. | $12.87 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalia Hernandez Bustos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.